Register entry
- Registered sites
- 1
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 1
- Base
- Japan
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| TATEYAMA KASEI CO.,LTD. | 1133, OGO, IMIZU, 9390302, Japan (JPN) | Active ingredient (API) manufacture | 3003973547691052179 |
Catalogue
Drug listings by form and route
22 active NDC listings: 2 bulk ingredient. By marketing category: BULK INGREDIENT 2.
| Dosage form | NDCs |
|---|---|
| powder | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| tateyama kasei co.,ltd. | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Istradefylline | powder | 53883-5784BULK INGREDIENT |
| - | Quazepam | powder | 53883-5783BULK INGREDIENT |
Compare
Comparable companies in Japan
- Sakai Chemical Industry Co., Ltd.1 site · 20 NDC
- KYOWA HAKKO BIO CO., LTD.1 site · 14 NDC
- Kyowa Kirin Co., Ltd.1 site · 11 NDC
- Titan Kogyo , Ltd.1 site · 8 NDC
- Kyowa Pharma Chemical Co., Ltd.1 site · 6 NDC
- Alps Pharmaceutical Ind. Co., Ltd.1 site · 5 NDC
- Kongo Chemical Co., Ltd.1 site · 5 NDC
- Yuki Gosei Kogyo Co., Ltd.1 site · 5 NDC
- Juzen Chemical Corporation1 site · 4 NDC
- Asahi Kasei Finechem Co., Ltd.1 site · 3 NDC
Enquiry
Common questions
- Is TATEYAMA KASEI CO.,LTD. FDA approved?
- TATEYAMA KASEI CO.,LTD. holds 1 FDA-registered establishment in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are TATEYAMA KASEI CO.,LTD.'s drugs manufactured?
- The FDA register lists IMIZU. Registered operations: active ingredient (API) manufacture.
- What drugs does TATEYAMA KASEI CO.,LTD. make?
- 2 products are listed under TATEYAMA KASEI CO.,LTD. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.